GenCurix Secures Patent for Rapid Molecular Diagnosis of Coronavirus... "PCR-Level On-Site Testing Possible"

[Asia Economy Reporter Hyunseok Yoo] GenCurix, a liquid biopsy molecular diagnostics specialist company, announced on the 16th that it has completed domestic patent registration for a rapid molecular diagnostic method for the coronavirus. The patent is titled "Coronavirus Diagnostic Method and Diagnostic Kit."

This patent is an on-site molecular diagnostic technology that allows visual confirmation of virus infection without expensive testing equipment such as PCR (polymerase chain reaction). This technology uses isothermal nucleic acid amplification and gene scissors (CRISPR) reactions to solve the false positive issues of existing rapid diagnostic products. It also enables nucleic acid amplification at PCR levels in a much shorter time than PCR, allowing highly accurate self-diagnosis.

A company representative stated, "Achieving high accuracy with existing technology required considerable costs and long testing times. The technology developed by the company this time enables rapid and accurate molecular diagnosis without expensive equipment, and it is expected to be actively used in various environments."

Last month, GenCurix was selected for a cross-ministerial full-cycle medical device R&D project related to this technology. Through this, the company will receive 5 billion KRW from the government to develop and commercialize a one-step system in the respiratory molecular diagnostics field.

Jangrae Cho, CEO of GenCurix, said, "Following the previous project selection and now the patent registration, the development of an all-in-one self molecular diagnostic platform will accelerate. It is expected that analysis from pre-processing of self-collected specimen samples to signal detection will be possible in one step."

He added, "In fields requiring precise analysis such as cancer, we plan to utilize high-sensitivity molecular diagnostic technology based on digital PCR. Starting with this patent, we will launch innovative products that can quickly and accurately detect various infectious disease viruses," he emphasized.

This content was produced with the assistance of AI translation services.